The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Gill and Okie, N Engl J Med 356(18):1801-1805 May 3, 2007.

Correction
PreviousPrevious
Volume 357:835 August 23, 2007 Number 8
NextNext

China and HIV — A Window of Opportunity

Since this article has no abstract, we have provided an extract of the first 100% of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Gill, B.
China and HIV — A Window of Opportunity. In the fourth paragraph from the end of the Perspective (page 1805), the first sentence should have read "Relying almost entirely on generic drugs produced in China, the country's first-line therapy regimens — zidovudine, didanosine, and nevirapine or stavudine, didanosine, and nevirapine — have severe side effects, raising concerns about adherence and the emergence of drug resistance," rather than "zidovudine, didanosine, and nevirapine or zidovudine, stavudine, and nevirapine." The text has been corrected on the Journal's Web site at www.nejm.org.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.